Presentation

0 Comments

20 December 2016

Oral antiplatelets in ACS PCI: Are we barking up the wrong tree?

Nick Curzen

Professor of Interventional Cardiology
Southampton University Hospitals NHS Trust

Previous | Next
Download

Summary

In this presentation, Professor Nick Curzen discusses the antiplatelet therapy in acute coronary syndromes. Clopidogrel works in most patients. There is no evidence of benefit of prasugrel or ticagrelor in PPCI. Clopidogrel is safer and cheaper than prasugrel and ticagrelor.

Download

Summary

In this presentation, Professor Nick Curzen discusses the antiplatelet therapy in acute coronary syndromes. Clopidogrel works in most patients. There is no evidence of benefit of prasugrel or ticagrelor in PPCI. Clopidogrel is safer and cheaper than prasugrel and ticagrelor.

You have to be a BCIS member to access this content

Either Sign in or register to become a member, today! Join BCIS Sign In